Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.41 |
| ▸ | FBP1 | P09467 | 2/20 | 0.40 |
| ▸ | PTGES2 | Q9H7Z7 | 5/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8002652 | 0.85 | L3MBTL1 (0.43) | NFE2L2FBP1PTGES2 | |
| SCHEMBL7990203 | 0.84 | NFE2L2 (0.47) | NFE2L2FBP1PTGES2CYP1A2CYP2C9 | |
| SCHEMBL7998331 | 0.82 | NFE2L2 (0.48) | NFE2L2FBP1PTGES2CYP1A2CYP2C9 | |
| SCHEMBL8002290 | 0.77 | MAOB (0.47) | NFE2L2FBP1PTGES2 | |
| SCHEMBL7989468 | 0.77 | NFE2L2 (0.40) | NFE2L2PTGES2 | |
| SCHEMBL7998337 | 0.77 | NFE2L2 (0.62) | NFE2L2FBP1PTGES2CYP1A2CYP2C9 | |
| SCHEMBL7998761 | 0.76 | NFE2L2 (0.34) | NFE2L2FBP1PTGES2 | |
| SCHEMBL8002639 | 0.76 | NFE2L2 (0.43) | NFE2L2FBP1PTGES2CYP1A2CYP2C9 | |
| SCHEMBL7998811 | 0.76 | LMNA (0.43) | NFE2L2FBP1PTGES2 | |
| SCHEMBL8001632 | 0.75 | MAPT (0.48) | NFE2L2FBP1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009120783-A1 | HIGH AFFINITY INHIBITORS OF HEPATITIS C VIRUS NS3/4A PROTEASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-10-01 | — | — | WO | disclosed |